Title : Evaluating the costs of glycemic response with canagliflozin versus dapagliflozin and empagliflozin as add-on to metformin in patients with type 2 diabetes mellitus in the United Arab Emirates.

Pub. Date : 2017 Jun

PMID : 28323512






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The cost associated with a 1% placebo-adjusted HbA1c reduction with each SGLT2 inhibitor as add-on to metformin was calculated based on NMA results and UAE drug costs. Metformin hemoglobin subunit alpha 1 Homo sapiens